Jean-Philippe Theurillat: Catalogue data in Autumn Semester 2020 |
| Name | Prof. Jean-Philippe Theurillat |
| Address | Institute of Oncology Research Via Vincenzo Vela 6 6500 Bellinzona SWITZERLAND |
| Telephone | 091 821 0075 |
| jeanphilippe.theurillat@hest.ethz.ch | |
| Department | Health Sciences and Technology |
| Relationship | Lecturer |
| Number | Title | ECTS | Hours | Lecturers | |
|---|---|---|---|---|---|
| 377-0517-00L | Oncology  Only for Human Medicine BSc | 2 credits | 2V | A. Alimonti, A. Calcinotto, A. Stathis, J.‑P. Theurillat | |
| Abstract | Advances in our knowledge of cancer genetics and the immune system are changing the ways in which we treat various types of cancer. This is a unique course designed to help students to learn about cutting-edge principle of cancer genetics, targeted and immunotherapies from leading expert in the field. | ||||
| Objective | Students will learn basic concepts of cancer patient’s management and anti-cancer therapy both clinically approved and experimental. | ||||
| Content | Basic knowledge in oncology - The cancer outbreak and its prevention - Tumor diagnostic, imaging and screening - Basic principle of cancer managment (neo-adjuvant, adjuvant, palliative. RT/Surgery/CT) - Management of tumor recurrence and Follow up Immuno-oncology - The promise of Immuno-oncology - Basic Tumor Immunology - Checkpoint Blockade - CAR T and other experimental Immunotherapies Oncology practice - Clinical application: Evidence Based Medicine in oncology - Clinical application: Immunology - Clinical application: Chemo-radiotherapy and Theragnostic - Clinical application: Targeted therapy in cancer Experimental oncology - Co-clinical trial: the relevance of mouse models - Next Generation sequencing and precision oncology - Microbiota and Cancer therapy - Liquid biopsy (CTC and clusters), proteomics, circulating DNA/RNA hip or hope?). Targeted therapy - From Arsenic Trioxide and Glivec to modern targeted therapies - Cancer Genomics and Epigenomics - Basic knowledge of signal transduction and cancer metabolism - Mechanism of resistance to targeted therapies Experimental oncology 2 - Senescence therapy and senolytic - Cancer metabolism (therapy and imaging) - Nanomedicine and cancer (approved and experimental) - How to do Oncology in the Big Pharma | ||||
| Prerequisites / Notice | Voraussetzungen: LE 377-0105-00L Bewegungsapparat LE 377-0107-00L Nervensystem LE 377-0201-00L Herz-Kreislauf-System LE 377-0203-00L Atmungs-System LE 377-0205-00L Nieren und Homöostase LE 377-0301-01L Blut, Immunsystem LE 377-0301-02L Ernährung und Verdauung LE 377-0301-03L Endokrinologie, Stoffwechsel LE 377-0401-00L Sinnesorgane LE 377-0403-00L Haut und Anhangsorgane | ||||